Active	Status	Sponsor type	Region	Phase	Filter
11 Active 1 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rammos, Christos
SAVioR, NCT04092972: Safety and Efficacy of Atherectomy on VasculaR Functions	Recruiting	N/A	30	Europe	Atherectomy, POBA and DCB	University Hospital, Essen, Straub Medical AG	Peripheral Arterial Disease, Claudication, Intermittent	07/21	08/21
NCT05055297: SELUTION4BTK Trial	Recruiting	N/A	376	Europe, US, RoW	SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA)	MedAlliance, LLC, NAMSA, Cordis Corporation	Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities	06/27	07/29
NCT06055920: The PEERLESS II Study	Recruiting	N/A	1200	Europe, Canada, US	FlowTriever System, Anticoagulation Agents	Inari Medical	Pulmonary Embolism	07/26	07/26
ELEGANCE, NCT04674969: Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature	Recruiting	N/A	5000	Europe, Canada, US, RoW	Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.	Boston Scientific Corporation	Peripheral Vascular Diseases	01/28	01/28